These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29807272)

  • 1. Over expression of circulating miR-155 predicts prognosis in diffuse large B-cell lymphoma.
    Ahmadvand M; Eskandari M; Pashaiefar H; Yaghmaie M; Manoochehrabadi S; Khakpour G; Sheikhsaran F; Montazer Zohour M
    Leuk Res; 2018 Jul; 70():45-48. PubMed ID: 29807272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-21 expression predicts prognosis in diffuse large B-cell lymphoma.
    Li J; Fu R; Yang L; Tu W
    Int J Clin Exp Pathol; 2015; 8(11):15019-24. PubMed ID: 26823838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance and detection of microRNA-21 in serum of patients with diffuse large B-cell lymphoma in Chinese population.
    Chen W; Wang H; Chen H; Liu S; Lu H; Kong D; Huang X; Kong Q; Lu Z
    Eur J Haematol; 2014; 92(5):407-12. PubMed ID: 24400911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expression of miRNA-224 predicts poor clinical outcome in diffuse large B-cell lymphoma treated with R-CHOP.
    Ni H; Wang X; Liu H; Tian F; Song G
    Biomarkers; 2015; 20(4):253-7. PubMed ID: 26301883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma.
    Marques SC; Ranjbar B; Laursen MB; Falgreen S; Bilgrau AE; Bødker JS; Jørgensen LK; Primo MN; Schmitz A; Ettrup MS; Johnsen HE; Bøgsted M; Mikkelsen JG; Dybkær K
    Exp Hematol; 2016 Apr; 44(4):238-46.e2. PubMed ID: 26854484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-23a expression in paraffin-embedded specimen correlates with overall survival of diffuse large B-cell lymphoma.
    Wang WL; Yang C; Han XL; Wang R; Huang Y; Zi YM; Li JD
    Med Oncol; 2014 Apr; 31(4):919. PubMed ID: 24659264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients.
    Hu M; Wang X; Liu N; Ding K; Zhang G; Liu X
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34109978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
    Troppan K; Wenzl K; Pichler M; Pursche B; Schwarzenbacher D; Feichtinger J; Thallinger GG; Beham-Schmid C; Neumeister P; Deutsch A
    Int J Mol Sci; 2015 Aug; 16(8):18077-95. PubMed ID: 26251897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
    Marchesi F; Regazzo G; Palombi F; Terrenato I; Sacconi A; Spagnuolo M; Donzelli S; Marino M; Ercolani C; Di Benedetto A; Blandino G; Ciliberto G; Mengarelli A; Rizzo MG
    J Exp Clin Cancer Res; 2018 May; 37(1):95. PubMed ID: 29716630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of microRNA-146b-5p in diffuse large B-cell lymphoma and its relationship with risk assessment].
    Cao QW; Li HY; Yao XX; Wang JF
    Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1010-4. PubMed ID: 23363792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly.
    Andrade TA; Evangelista AF; Campos AH; Poles WA; Borges NM; Camillo CM; Soares FA; Vassallo J; Paes RP; Zerbini MC; Scapulatempo C; Alves AC; Young KH; Colleoni GW
    Oncotarget; 2014 Dec; 5(23):11813-26. PubMed ID: 25544772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
    Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating exosomal microRNAs as diagnostic and prognostic biomarkers in patients with diffuse large B-cell lymphoma.
    Cao D; Cao X; Jiang Y; Xu J; Zheng Y; Kang D; Xu C
    Hematol Oncol; 2022 Apr; 40(2):172-180. PubMed ID: 34874565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone.
    Wu PY; Zhang XD; Zhu J; Guo XY; Wang JF
    Hum Pathol; 2014 Aug; 45(8):1664-73. PubMed ID: 24931464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of MiRNA in Patients with Diffuse Large B-Cell Lymphoma: a Meta-Analysis.
    Zheng Z; Li X; Zhu Y; Gu W; Xie X; Jiang J
    Cell Physiol Biochem; 2016; 39(5):1891-1904. PubMed ID: 27771712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiomirs expression profiling in diffuse large B-Cell lymphoma.
    Borges NM; do Vale Elias M; Fook-Alves VL; Andrade TA; de Conti ML; Macedo MP; Begnami MD; Campos AH; Etto LY; Bortoluzzo AB; Alves AC; Young KH; Colleoni GW
    Oncotarget; 2016 Jan; 7(4):4806-16. PubMed ID: 26683099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of microRNA-129-5p predicts poor clinical outcome in diffuse large B cell lymphoma (DLBCL).
    Hedström G; Thunberg U; Berglund M; Simonsson M; Amini RM; Enblad G
    Int J Hematol; 2013 Apr; 97(4):465-71. PubMed ID: 23463124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma.
    Jia YJ; Liu ZB; Wang WG; Sun CB; Wei P; Yang YL; You MJ; Yu BH; Li XQ; Zhou XY
    Leukemia; 2018 Mar; 32(3):703-711. PubMed ID: 29135973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
    Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK
    Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.